Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Rapt Therapeutics Inc
About RAPT
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients living with inflammatory and immunological diseases. Its lead drug candidate, RPT904, is a half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobin E (IgE), which is being developing for the treatment of food allergy, chronic spontaneous urticaria (CSU) and potentially other inflammatory diseases. The Company’s oncology drug candidate, tivumecirnon, is an oral small-molecule C-C motif chemokine receptor 4 (CCR4) antagonist designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors.
Find out what a historical investment in Rapt Therapeutics Inc would be worth today using our RAPT stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy RAPT shares in Australia?
Buying RAPT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Rapt Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RAPT
What is the ticker symbol of Rapt Therapeutics Inc?
The ticker symbol for Rapt Therapeutics Inc is RAPT.
How much is one share of RAPT?
One share of RAPT is valued at $58.02 as of 21 May 2026.
What is the market capitalisation of Rapt Therapeutics Inc RAPT?
As of 21 May 2026 Rapt Therapeutics Inc has a market cap of -.
What is the 52-week high for Rapt Therapeutics Inc stock?
The Rapt Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for Rapt Therapeutics Inc stock?
The Rapt Therapeutics Inc 52-week low stock price is $NaN.
Can I buy RAPT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RAPT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RAPT on Stake
- Buy RAPT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RAPT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RAPT related stocks